On air · 1 of 3 networks
Legend Biotech
- legendbiotech.com
- US
- 2,661 employees
Legend Biotech’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 39. Watch Legend Biotech with Starter to get each new one in your feed.
Watchlist with Starter · $49/mo
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksOct 2026 | Checked | Next step |
|---|---|---|---|---|---|
| Running | 36 | Checked 29 Oct 2026 | See all 39 ads → | ||
| Meta | Not checked | — | |||
| None recorded | 0 | No ads found on the Google Ads Transparency Center | Checked 3 Oct 2026 | Collect them with the API → |
Legend Biotech has 36 live LinkedIn ads. We recorded no Google ads on 3 Oct 2026.
Latest ads
- LINKEDIN · JOBSince 3 Apr 2024
- LINKEDIN · FOLLOWRecorded 25 Sept 2026
Get the latest jobs and industry news
- LINKEDIN · IMAGERecorded 9 Oct 2026
Progress is personal. At Legend Biotech, that means every discovery is driven by the people behind the science and the patients who inspire our work. Every step forward reflects our commitment to creating new possibilities for patients and their families. #CellTherapy #PatientsFirst #CancerResearch
- LINKEDIN · IMAGERecorded 9 Oct 2026
Five years of follow-up can provide an important perspective on the evolving understanding of cell therapy in multiple myeloma. At #IMS2026, we presented long-term findings from CARTITUDE-2 Cohort A in patients with relapsed or refractory multiple myeloma (RRMM) treated as early as second line. Learn more about the data presented at the 2026 International Myeloma Society Annual Meeting: https://bit.ly/4hM5WuA #LegendBiotech #IMS2026 #MultipleMyeloma #CellTherapy #CART
- LINKEDIN · VIDEORecorded 25 Sept 2026
New data is coming at #IMS26. At the 23rd International International Myeloma Society Annual Meeting in Glasgow, Legend Biotech will present data from our CAR-T cell therapy, including long-term, post-authorization and real-world findings. These insights build on learnings from our clinical program as we continue our focus on advancing scientific innovation and reaching patients globally. Learn more about the data we’ll be sharing in Glasgow: https://bit.ly/4xITIZj #LegendBiotech #CellTherapy #ClinicalResearch
- LINKEDIN · IMAGERecorded 25 Sept 2026
Thank you to Fierce Pharma and Ruojing (Angus) Liu for the conversation about this next chapter at Legend Biotech. There’s important work ahead as we continue investing in the future of cell therapy. I’m excited to be working alongside our teams to keep that progress moving forward. Read more here: https://lnkd.in/g2zMmt4w #WeAreLegend #CellTherapy
6 of 39 adsSign up to see every Legend Biotech ad, filter by format and date, and get alerts on new ones.
See all 39 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.